MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2397-2402

  Liang, Hong Liang ^a,c   Hu, Ai Ping ^b   Li, Sen Lin ^c   Xie, Jia Ping ^c   Ma, Qing Zhu ^c   Liu, Ji Yong ^a  

^a SHANDONG UNIVERSITY   (China)

^b Department of Oncology Liaocheng Tumor Hospital   (China)

^c LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Cell proliferation; Colorectal cancer; CYLD; miR 454

Indexed keywords

3' UNTRANSLATED REGION; CYLD PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN454 MICRORNA, HUMAN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84929208809     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2397     Document Type: Article

References (26)

1. Alameda JP, Moreno-Maldonado R, Navarro M, et al (2010). An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene, 29, 6522-32.
2. Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5.
3. Andre T, Tuvignon N, Taieb J, et al (2010). Operable colon cancer: initial strategy. Rev Prat, 60, 1089-93.
4. Aschele C, Bergamo F, Lonardi S (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev, 35, 509-16.
5. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
6. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66.
7. Chen P, Wang BL, Pan BS, et al (2014). MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer Prev, 15, 9185-90.
8. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.
9. Gao Y, Li BD, Liu YG (2013). Effect of miR27a on proliferation and invasion in colonic cancer cells. Asian Pac J Cancer Prev, 14, 4675-8.
10. Iliopoulos D, Jaeger SA, Hirsch HA, et al (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell, 39, 493-506.
11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
12. Kinoshita H, Okabe H, Beppu T, et al (2013). CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma. Mol Clin Oncol, 1, 309-14.
13. Knudsen KE, Diehl JA, Haiman CA, et al (2006). Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 1620-8.
14. Massoumi R, Chmielarska K, Hennecke K, et al (2006). Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell, 125, 665-77.
15. Miliani de Marval P, Lutfeali S, Jin JY, et al (2011). CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. Cancer Prev Res, 4, 851-9.
16. Primrose JN (2010). Surgery for colorectal liver metastases. Br J Cancer, 102, 1313-8.
17. Raman M, Ambalam P, Kondepudi KK, et al (2013). Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes, 4, 181-92.
18. Ratschiller D, Heighway J, Gugger M, et al (2003). Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol, 21, 2085-93.
19. Rico-Rosillo MG, Vega-Robledo GB, Oliva-Rico D (2014). The role and importance of the microRNAs in the diagnosis and development of diseases. Rev Med Inst Mex Seguro Soc, 52, 302-7.
20. Roy AL, Carruthers C, Gutjahr T, et al (1993). Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature, 365, 359-61.
21. Sharma M, Sharma S, Arora M, et al (2013). Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909. Gene, 522, 60-4.
22. Shi L, Wang Z, Sun G, et al (2014). miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med, 16, 517-28.
23. Suppiah A, Hartley JE, Monson JR (2009). Advances in radiotherapy in operable rectal cancer. Dig Surg, 26, 187-99.
24. Xia JT, Chen LZ, Jian WH, et al (2014). MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kappaB signaling. J Transl Med, 12, 33.
25. Zhang L, Dong Y, Zhu N, et al (2014). microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer, 13, 124.
26. Zhong Q, Wang T, Lu P, et al (2014). miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res, 92, 619-26.